Their results suggest that a negative minimal residual disease status after treatment appears to be associated with improved survival. (sciencedaily.com)
A new study published online by JAMA Oncology examines the assessment of minimal residual disease in patients newly treated for multiple myeloma as a factor in survival outcomes. (sciencedaily.com)
Once validated, the model might be applied «in comparison or in combination with» other biologically based prognostic tools, or with minimal residual disease assessment after treatment, they proposed. (cancernetwork.com)